Clinical Trial Update: A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting [Phase 4]

View source ↗

Summary

Phase IV trial of Cesamet (nabilone) plus standard antiemetic therapy for chemotherapy-induced nausea and vomiting has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• CESAMET (nabilone)

Snippet

Sponsor: Veeda Oncology | Conditions: Nausea and Vomiting | Phase 4 | Status: TERMINATED